Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer

被引：0
|
作者：
Stevic, Ivan [1 ,2 ]
Dembinski, Tom C. [1 ,2 ]
Leslie, William D. [3 ,4 ]
机构：
[1] Univ Manitoba, Dept Clin Biochem, Winnipeg, MB, Canada
[2] Diagnost Serv Manitoba, Winnipeg, MB, Canada
[3] Univ Manitoba, Dept Med, Winnipeg, MB, Canada
[4] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada
来源：
CLINICAL BIOCHEMISTRY | 2014年 / 47卷 / 12期
关键词：
D O I：
10.1016/j.clinbiochem.2014.06.025
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
549
引用
收藏
页码：1142 / 1142
页数：1
相关论文
共 50 条
  • [1] Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer
    Stevic, Ivan
    Dembinski, Tom C.
    Pathak, K. Alok
    Leslie, William D.
    [J]. CLINICAL BIOCHEMISTRY, 2015, 48 (10-11) : 658 - 661
  • [2] Serum thyroglobulin as a prognostic marker before radioiodine ablation in patients with differentiated thyroid cancer
    Takacsova, E.
    Kralik, R.
    Kausitz, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S542 - S542
  • [3] Thyroglobulin Flare Response After Radioiodine Ablation in 2 Patients With Differentiated Thyroid Cancer
    Tsang, James F.
    Levin, Daniel P.
    Leslie, William D.
    [J]. CLINICAL NUCLEAR MEDICINE, 2015, 40 (05) : 421 - 422
  • [4] Thyroglobulin autoantibodies before radioiodine ablation predict differentiated thyroid cancer outcome
    Trimboli, Pierpaolo
    Zilioli, Valentina
    Imperiali, Mauro
    Giovanella, Luca
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (12) : 1995 - 2001
  • [5] Retrospective case–control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer
    Ken Watanabe
    Takao Igarashi
    Mayuki Uchiyama
    Takayuki Ishigaki
    Hiroya Ojiri
    [J]. Japanese Journal of Radiology, 2024, 42 : 391 - 397
  • [6] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    Castagna, M. G.
    Cantara, S.
    Pacini, F.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (10) : 1087 - 1094
  • [7] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
    M. G. Castagna
    S. Cantara
    F. Pacini
    [J]. Journal of Endocrinological Investigation, 2016, 39 : 1087 - 1094
  • [8] The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
    Kim, Hee Kyung
    Yoon, Jee Hee
    Cho, Jin Seong
    Kwon, Seong Young
    Yoo, Su Woong
    Kang, Ho-Cheol
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (05): : 1164 - 1172
  • [9] Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer
    Watanabe, Ken
    Igarashi, Takao
    Uchiyama, Mayuki
    Ishigaki, Takayuki
    Ojiri, Hiroya
    [J]. JAPANESE JOURNAL OF RADIOLOGY, 2024, 42 (4) : 391 - 397
  • [10] The impact of post-radioiodine therapy SPECT/CT on early risk stratification in differentiated thyroid cancer; a bi-institutional study
    Szujo, Szabina
    Sira, Livia
    Bajnok, Laszlo
    Bodis, Beata
    Gyory, Ferenc
    Nemes, Orsolya
    Rucz, Karoly
    Kenyeres, Peter
    Valkusz, Zsuzsanna
    Sepp, Krisztian
    Schmidt, Erzsebet
    Szabo, Zsuszanna
    Szekeres, Sarolta
    Zambo, Katalin
    Barna, Sandor
    Nagy, Endre V.
    Mezosi, Emese
    [J]. ONCOTARGET, 2017, 8 (45) : 79825 - 79834
12345